JAK/STAT signaling has been described as one of the major signaling pathways aberrantly activated in EOC and inhibition of JAK1 by small molecule inhibitors was shown to suppress cancer progression of EOC and other cancer types [44,64]. The gene discussed is JAK1; the disease is cancer.